Nazione: Irlanda
Lingua: inglese
Fonte: HPRA (Health Products Regulatory Authority)
marbofloxacin
Sogeval
QJ01MA93
100 Milligram
Tablets Chewable
Canine
Antibacterial
Authorised
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Efex 100 mg chewable tablets for dogs. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Chewable tablet Clover-shaped scored beige tablet. The tablet can be divided into four equal parts. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In dogs Marbofloxacin is indicated in the treatment of: - skin and soft tissue infections (skinfold pyoderma, impetigo, folliculitis, furunculosis, cellulitis) caused by susceptible strains of _organisms._ - urinary tract infections (UTI) caused by susceptible strains of organisms associated or not with prostatitis or epididymitis. - respiratory tract infections caused by susceptible strains of _organisms_. 4.3 CONTRAINDICATIONS Do not use in dogs aged less than 12 months, or less than 18 months for giant breeds of dogs with a longer growth period. Do not use in cases of hypersensitivity to (fluoro)quinolones. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES A low urinary pH could have an inhibitory effect on the activity of marbofloxacin. One tablet contains: ACTIVE SUBSTANCE: Marbofloxacin 100.0 mg EXCIPIENTS: For a full list of excipients, see section 6.1. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 20/08/2013_ _CRN 7015117_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS The chewable tablets are flavoured. In order to avoid any accidental ingestion, store tablets out of reach of the animals. The fluoroquinolones have been shown to induce erosion of articular cartilage in juvenile dogs and care should be taken to dose accurately especially in young animals. The fluoroquinolones ar Leggi il documento completo